Obesity and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60.

Translational Research : the Journal of Laboratory and Clinical Medicine
Stefan S FajansMing Chen

Abstract

We studied the genetic and clinical features of diabetic subjects in a 5-generation Michigan-Kentucky pedigree ascertained through a proband with pancreatic agenesis and homozygous for the IPF1 mutation Pro63fsx60. Diabetic and nondiabetic family members were genotyped and phenotyped. We also carried out genetic studies to determine the history of the IPF1 mutation in the Michigan-Kentucky family and a Virginia family with the same mutation. We identified 110 individuals; 34 are currently being treated for diabetes and 10 of these are Pro63fsX60 carriers (ie, MODY4). Subjects with MODY as well as those with type 2 diabetes are characterized by obesity and hyperinsulinemia. Genetic studies suggest that the IPF1 mutation was inherited from an ancestor common to both the Michigan-Kentucky and Virginia families. MODY4 and type 2 diabetes in the Michigan-Kentucky pedigree are associated with obesity and hyperinsulinemia. Obesity and hyperinsulinemia have been observed occasionally in other subtypes of MODY, which suggests that hyperinsulinemia may be a general phenomenon when obesity occurs in MODY subjects. Hypoinsulinemia in nonobese MODY subjects seems to be caused by a functional defect in the beta cell. Genetic testing should b...Continue Reading

References

May 30, 1992·Lancet·A T HattersleyJ S Wainscoat
Mar 11, 1993·The New England Journal of Medicine·P FroguelP Passa
Nov 5, 1997·Nature Genetics·D A StoffersJ F Habener
May 10, 2000·Nature Genetics·D F GudbjartssonA Kong
Sep 29, 2001·The New England Journal of Medicine·S S FajansK S Polonsky
Sep 13, 2003·The Journal of Clinical Endocrinology and Metabolism·Valerie M SchwitzgebelJacques Philippe
Sep 17, 2004·The Journal of Clinical Investigation·Rohit N KulkarniC Ronald Kahn
Dec 22, 2005·Nature Genetics·Helge RaederPål Rasmus Njølstad

❮ Previous
Next ❯

Citations

Oct 14, 2011·Current Diabetes Reports·Siri Atma W GreeleyGraeme I Bell
Dec 30, 2014·Molecular Aspects of Medicine·Emilyn U AlejandroErnesto Bernal-Mizrachi
Jul 27, 2011·Diabetes Care·Stefan S Fajans, Graeme I Bell
Apr 25, 2017·Clinical Genetics·L A CaetanoM G Teles
Nov 7, 2015·Clinical Medicine Insights. Endocrinology and Diabetes·Christian MangrumVijay Shivaswamy
Aug 1, 2015·Journal of Pediatric Endocrinology & Metabolism : JPEM·Ahmet AnıkEce Böber
Mar 14, 2020·Molecular Reproduction and Development·Fuminori TaniharaTakeshige Otoi
Jan 13, 2015·Journal of Pediatric Endocrinology & Metabolism : JPEM·Ahmet AnıkEce Böber
Sep 8, 2019·Wiener klinische Wochenschrift·Jana UrbanovaJan Broz
Jun 23, 2018·Current Diabetes Reports·May SanyouraRochelle Naylor
Jul 25, 2019·Frontiers in Endocrinology·Mingqun DengTong Wang
Dec 31, 2019·Current Diabetes Reviews·Madalena Sousa, Jácome Bruges-Armas
Feb 3, 2021·The Journal of Clinical Investigation·Haichen ZhangToni I Pollin
Feb 11, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Jiangman LiuJingshan Shi
Aug 9, 2020·Journal of Diabetes and Its Complications·Ramasamy AarthyViswanathan Mohan
Mar 23, 2021·European Journal of Medical Genetics·Gabriella de M AbreuMário Campos Junior
Apr 15, 2021·Journal of Pediatric Endocrinology & Metabolism : JPEM·Emily BreidbartWendy K Chung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.